Search research articles
Contact Us
Filters
Showing results (151-160 of 175) with videos related to
Page
of 18
Sort By:
Lancet (London, England)
|
February 21, 1987
Prevalence of human T-lymphotropic retroviruses type III (HIV) and type IV in Ivory Coast
F Denis, F Barin, G Gershy-Damet, et al.
AIDS Research and Human Retroviruses
|
September 1, 1996
Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping
F Barin, Y Lahbabi, L Buzelay, et al.
IARC Scientific Publications
|
January 1, 1984
Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma
P Coursaget, J P Chiron, J L Barres, et al.
Epidemiology and Infection
|
December 23, 2016
Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys
L Leon, S Kasereka, F Barin, et al.
La Revue Du Praticien
|
May 21, 1977
[Vaccination, a method of hepatitis B prevention]
P Maupas, P Coursaget, A Goudeau, et al.
AIDS (London, England)
|
September 4, 1998
Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing
J N Nkengasong, B Willems, W Janssens, et al.
AIDS Research and Human Retroviruses
|
March 31, 1998
Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization
R Cheingsong-Popov, S Osmanov, C P Pau, et al.
Blood
|
January 1, 1987
Immunogenic nature of a Pol gene product of HTLV-III/LAV
J S Allan, J E Coligan, T H Lee, et al.
Medecine Et Maladies Infectieuses
|
July 22, 2010
[Specific diagnosis and follow-up of HIV-1 group O infection: RES-O data]
A Depatureaux, M Leoz, F De Oliveira, et al.
Medecine Et Maladies Infectieuses
|
March 23, 2005
[Human immunodeficiency virus type 1 subtypes in cohort of infected patients, Saint-Etienne, France, from 1984 to 2003]
M Granjean, T Bourlet, P Berthelot, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 175) with videos related to
Sort By:
Page
of 18
Lancet (London, England)
|
February 21, 1987
Prevalence of human T-lymphotropic retroviruses type III (HIV) and type IV in Ivory Coast
F Denis, F Barin, G Gershy-Damet, et al.
AIDS Research and Human Retroviruses
|
September 1, 1996
Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping
F Barin, Y Lahbabi, L Buzelay, et al.
IARC Scientific Publications
|
January 1, 1984
Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma
P Coursaget, J P Chiron, J L Barres, et al.
Epidemiology and Infection
|
December 23, 2016
Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys
L Leon, S Kasereka, F Barin, et al.
La Revue Du Praticien
|
May 21, 1977
[Vaccination, a method of hepatitis B prevention]
P Maupas, P Coursaget, A Goudeau, et al.
AIDS (London, England)
|
September 4, 1998
Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing
J N Nkengasong, B Willems, W Janssens, et al.
AIDS Research and Human Retroviruses
|
March 31, 1998
Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization
R Cheingsong-Popov, S Osmanov, C P Pau, et al.
Blood
|
January 1, 1987
Immunogenic nature of a Pol gene product of HTLV-III/LAV
J S Allan, J E Coligan, T H Lee, et al.
Medecine Et Maladies Infectieuses
|
July 22, 2010
[Specific diagnosis and follow-up of HIV-1 group O infection: RES-O data]
A Depatureaux, M Leoz, F De Oliveira, et al.
Medecine Et Maladies Infectieuses
|
March 23, 2005
[Human immunodeficiency virus type 1 subtypes in cohort of infected patients, Saint-Etienne, France, from 1984 to 2003]
M Granjean, T Bourlet, P Berthelot, et al.
Page
of 18